T. Rowe Price Associates »

Lyell Immunopharma shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $264k 13k 20.11
2025-12-31 $405k 13k 30.85
2025-09-30 $214k 13k 16.30
2025-06-30 $2.7M 306k 8.84

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Lyell Immunopharma

Arch Venture Corp
GSK
Vanguard Capital Management
Orland Properties
BlackRock
Almitas Capital
Foresite Capital Management V
Millennium Management
Opaleye Management
venBio Partners
Geode Capital Management
Alphabet
Sc China Holding
Renaissance Technologies
Northern Trust

View all funds holding Lyell Immunopharma